Search

everythinglearnresearchcommunity

for

Search:↓

Some nonsurgical hair loss treatments are effective, especially if started early.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Thuja orientalis and Thuja occidentalis essential oils have medicinal properties useful for developing treatments with antimicrobial and bioactive effects.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Rice bran extract might help prevent hair loss.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

PRP and LLLT can improve hair growth in AGA, but more research needed.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Androgens can both increase and decrease hair growth in different parts of the body.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.